300562 Guangdong Transtek Medical Electronics
- 9.45
- +0.60+6.78%
Guangdong Transtek Medical Electronics News
Lexin Healthcare (300562.SZ): Net profit of 136.656 million yuan for the first quarter reversed the year-on-year loss
On April 24, Gelonghui Medical (300562.SZ) released its first quarter report. Operating revenue was 249 million yuan, up 52.93% year on year, net profit of 136.656 million yuan, reversed year-on-year losses, after deducting non-net profit of 11.916,600 yuan, reversing year-on-year losses, with basic earnings of 0.06 yuan per share.
Lexin Healthcare (300562.SZ) plans to distribute 10 shares of 1.51,075 yuan to be deducted from interest on April 25
Lexin Healthcare (300562.SZ) announced that the company's 2023 equity distribution plan: to all shareholders for every 10...
Happy Healthcare (300562.SZ): Proposed 2024 Employee Stock Ownership Plan
Gelonghui, April 10 | Lexin Healthcare (300562.SZ) announced the 2024 employee stock ownership plan. The number of underlying shares to be held by the employee's shareholding plan is no more than 1.50 million shares, accounting for 0.69% of the company's total share capital of 216.90.118 million shares on the day the draft employee shareholding plan was announced. The maximum amount of capital to be raised in the employee stock ownership plan is 6.87 million yuan. Using “shares” as the subscription unit, each share is 1.00 yuan. The price of the employee's shareholding plan to buy back shares is 4.58 yuan/share.
Transtek Medical Electronics Gets Nod to Sell Blood Pressure Monitoring Device in Canada
Guangdong Transtek Medical Electronics (SHE:300562) received approval from Canada's medical regulators for the registration of its electronic blood pressure monitor medical device, according to the co
Happy Healthcare (300562.SZ): The application for a medical device registration certificate was accepted
Gelonghui, April 7 | Lexin Healthcare (300562.SZ) announced that it recently received a response from Health Canada's Medical Devices Division Equipment Licensing Service Division and learned that the company's application for registration of an electronic blood pressure monitor medical device has been accepted.
Lexin Healthcare (300562.SZ): 0.60% of shares have been repurchased
Gelonghui, April 1, 丨 Lexin Medical (300562.SZ) announced that as of March 31, 2024, the company had repurchased a total of 1,311,600 shares of the company through centralized bidding through a special securities repurchase account, accounting for 0.60% of the company's current total share capital (the company's current total share capital is 216,901,188 shares). From the initial repurchase until March 31, 2024, the highest transaction price for the company to repurchase shares was 9.66 yuan/share, the lowest transaction price was 6.05 yuan/share, and the total amount paid was 10,759,801.00 yuan (excluding transaction fees).
Guangdong Transtek Medical Electronics (SZSE:300562) Strong Profits May Be Masking Some Underlying Issues
Following the solid earnings report from Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562), the market responded by bidding up the stock price. While the profit numbers were good, our ana
Earnings Release: Here's Why Analysts Cut Their Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Price Target To CN¥13.70
Last week, you might have seen that Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) released its full-year result to the market. The early response was not positive, with shares down 2.3
Happy Healthcare (300562.SZ): The application for registration of the electronic blood pressure monitor medical device 510 (k) has been accepted
On March 27, Ge Longhui Medical (300562.SZ) announced that the company recently received the “Complication Letter” from the US FDA and learned that the 510 (k) registration application for an electronic blood pressure monitor medical device declared by the company has been accepted.
Lexin Healthcare (300562.SZ): Net profit of 34.3673 million yuan in 2023, plans to pay 10 to 1.5 yuan
Gelonghui, March 25 | Lexin Healthcare (300562.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 884 million yuan, a year-on-year decrease of 16.98%; net profit attributable to shareholders of listed companies was 34,3673 million yuan, turning a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 225.392 million yuan; basic earnings per share of 0.1597 yuan; plans to distribute a cash dividend of 1.50 yuan (tax included) for every 10 shares to all shareholders
The Market Lifts Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Shares 40% But It Can Do More
Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) shareholders are no doubt pleased to see that the share price has bounced 40% in the last month, although it is still struggling to make u
Lexin Healthcare (300562.SZ): Initial repurchase of 260,000 shares
Gelonghui, Feb. 6 | Lexin Healthcare (300562.SZ) announced that on February 6, 2024, the company repurchased 260,000 shares of the company's shares through a dedicated securities account through centralized bidding, accounting for 0.12% of the company's current total share capital (the company's current total share capital is 216,901,188 shares). The highest transaction price for the initial repurchase was 7.16 yuan/share, the lowest transaction price was 6.41 yuan/share, and the total amount paid was 1,722,544 yuan.
It's Down 30% But Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Could Be Riskier Than It Looks
The Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) share price has fared very poorly over the last month, falling by a substantial 30%. Instead of being rewarded, shareholders who ha
Individual Investors Invested in Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Copped the Brunt of Last Week's CN¥373m Market Cap Decline
Key Insights Guangdong Transtek Medical Electronics' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public 44% of the busin
Lexin Healthcare (300562.SZ): Plans to spend 20 million yuan to 40 million yuan to buy back the company's shares
Gelonghui, Feb. 1 | Happy Healthcare (300562.SZ) announced that the company plans to use its own funds to repurchase RMB common shares (A shares) issued by the company through centralized bidding for share incentives or employee shareholding plans. The total amount of shares to be repurchased is not less than RMB 20 million (including the number of shares) and not more than RMB 40 million (including the number of shares); the repurchase price is not higher than RMB 16.00 per share (inclusive). Based on the maximum proposed repurchase price of 16.00 yuan/share (inclusive) and the lower limit of the total amount to be used to repurchase shares of 20 million yuan (inclusive), the number of shares to be repurchased is approximately 12
Lexin Healthcare (300562.SZ): Application for medical device registration certificate accepted and medical device registration certificate obtained
Gelonghui, January 22 | Happy Healthcare (300562.SZ) announced that it recently received responses from the US FDA and Health Canada Medical Device Division Equipment Licensing Service Division. It learned that the company's electronic blood pressure monitor medical device registration application with the US FDA has been accepted, and that the electronic blood pressure monitor medical device registration application for the medical device registration application by Health Canada's Medical Devices Division has been approved.
Happy Healthcare (300562.SZ): Net profit of 32 million yuan to 36 million yuan in 2023, which is expected to turn a loss into a profit
Gelonghui, January 21丨Lexin Healthcare (300562.SZ) announced its 2023 annual results forecast. Net profit attributable to shareholders of listed companies during the reporting period was 32 million yuan to 36 million yuan, which is expected to turn a loss into a profit; net profit after deducting non-recurring profit and loss of 20 million yuan to 24 million yuan. During the reporting period, the company was committed to improving the overall management level and quality of operations. By improving the budget control system, the management continued to strengthen cost reduction and efficiency measures to enhance the core competitiveness of the product, and achieved significant improvements in unit labor efficiency output; in terms of total supply chain costs, direct labor and manufacturing costs
Lexin Medical (300562.SZ): The application for renewal of medical device registration for wrist single-lead ECG collector and medical device registration for upper arm electronic blood pressure monitors has been accepted
Gelonghui, January 18 | Lexin Medical (300562.SZ) announced that the company recently received the “Certificate of Acceptance” issued by the Guangdong Drug Administration and learned that the company's application for continuing registration of wrist single-lead ECG collector medical devices and medical device registration for upper arm electronic blood pressure monitors has been accepted.
Lexin Medical (300562.SZ) application for a medical device registration certificate was accepted
Lexin Medical (300562.SZ) announced that the company recently received the “Acceptance Certificate...” issued by the Guangdong Drug Administration
Lexin Medical (300562.SZ): The declared electronic blood pressure monitor medical device registration certificate application has been accepted
Glonghui, December 14|Lexin Medical (300562.SZ) announced that the company recently received the “Certificate of Acceptance” (acceptance number: 0010600120231396) issued by the Guangdong Drug Administration and learned that the electronic blood pressure monitor medical device registration certificate application filed by the company has been accepted.
Analysis
Price Target
No Data
